Skip to content

Versterk je Enkel; Blessurepreventie in je broekzak?

Evaluation of the implementation effectiveness of the 'Versterk je Enkel' App to prevent recurrent ankle sprains; Injury prevention in your pocket?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21092
Enrollment
190
Registered
2013-06-07
Start date
2013-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle sprain, Prevention, App, implementation, Cost-effectiveness, Compliance, Enkelverstuiking, Preventie, Implementatie, Kosten-effectiviteitsanalyse, Compliantie

Interventions

After subjects have finished ankle sprain treatment by means of usual care, they will be randomized to any of the two study groups. Subjects allocated to the 'regular' intervention group will receive

Sponsors

EMGO Institute for Health and Care research of the VU University Medical Center VeiligheidNL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals who have sustained an ankle sprain within the past two months, and who are currently being treated for that injury by either a physiotherapist, physician, sports physician, or orthopedic surgeon are eligible for inclusion.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Secondary

MeasureTime frame
Secondary outcome measures include injury recurrence incidence, costs of injury (and cost-effectiveness of the intervention), as well as barriers and facilitators towards the use of the eight-week training program, including knowledge and attitude regarding the prevention of ankle sprain recurrences.

Primary

MeasureTime frame
Primary outcome measures will be compliance to the prescribed eight-week program.

Contacts

Public ContactEvert Verhagen

Department of Public and Occupational Health VU University Medical Center Van der Boechorststraat 7

E.verhagen@vumc.nl+31 204449684

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)